TW200503798A - Arsenic-containing pharmaceutical composition for treatment of tumor/cancer in conjunction with radiation therapy - Google Patents

Arsenic-containing pharmaceutical composition for treatment of tumor/cancer in conjunction with radiation therapy

Info

Publication number
TW200503798A
TW200503798A TW093112112A TW93112112A TW200503798A TW 200503798 A TW200503798 A TW 200503798A TW 093112112 A TW093112112 A TW 093112112A TW 93112112 A TW93112112 A TW 93112112A TW 200503798 A TW200503798 A TW 200503798A
Authority
TW
Taiwan
Prior art keywords
arsenic
tumor
cancer
conjunction
treatment
Prior art date
Application number
TW093112112A
Other languages
Chinese (zh)
Other versions
TWI335229B (en
Inventor
yun-liang Lai
Yu-Ren Chen
Yu-Fang Hu
Ji-Liang Kang
Guang-Jun Qiu
Original Assignee
Tty Biopharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tty Biopharm Co Ltd filed Critical Tty Biopharm Co Ltd
Priority to TW093112112A priority Critical patent/TW200503798A/en
Publication of TW200503798A publication Critical patent/TW200503798A/en
Application granted granted Critical
Publication of TWI335229B publication Critical patent/TWI335229B/zh

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

This invention provides an arsenic-containing pharmaceutical composition for treatment of tumor/cancer in conjunction with radiation therapy.
TW093112112A 2004-04-30 2004-04-30 Arsenic-containing pharmaceutical composition for treatment of tumor/cancer in conjunction with radiation therapy TW200503798A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW093112112A TW200503798A (en) 2004-04-30 2004-04-30 Arsenic-containing pharmaceutical composition for treatment of tumor/cancer in conjunction with radiation therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW093112112A TW200503798A (en) 2004-04-30 2004-04-30 Arsenic-containing pharmaceutical composition for treatment of tumor/cancer in conjunction with radiation therapy

Publications (2)

Publication Number Publication Date
TW200503798A true TW200503798A (en) 2005-02-01
TWI335229B TWI335229B (en) 2011-01-01

Family

ID=45075010

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093112112A TW200503798A (en) 2004-04-30 2004-04-30 Arsenic-containing pharmaceutical composition for treatment of tumor/cancer in conjunction with radiation therapy

Country Status (1)

Country Link
TW (1) TW200503798A (en)

Also Published As

Publication number Publication date
TWI335229B (en) 2011-01-01

Similar Documents

Publication Publication Date Title
GB2471588A (en) Therapeutic peptidomimetic macrocycles
IL184617A0 (en) Dr5 antibodies and uses thereof
MX339142B (en) Combinations and modes of administration of therapeutic agents and combination therapy.
MX2009006779A (en) Vegf-specific antagonists for adjuvant and neoadjuvant therapy and the treatment of early stage tumors.
SG10201811480WA (en) Therapeutic compounds and compositions
MX2019015200A (en) Diarylhydantoin compounds.
IL164599A0 (en) Combination therapy for the treatment of cancer
MX2007003506A (en) Cancer combination therapy comprising azd2171 and imatinib.
MX2007003505A (en) Combination comprising zd6474 and an imatinib.
HK1071310A1 (en) Combination therapy for the treatment of cancer
TW200633700A (en) Methods of using temozolomide formulation intrathecally in the treatment of cancers
MX2008015775A (en) Compounds and compositions for treatment of cancer.
HK1123976A1 (en) Combination of azd2171 and pemetrexed azd2171
IL307964A (en) Combination therapy for cancer treatment
TN2009000490A1 (en) Cancer treatment combination therapy comprising vinflunine and trastuzumab
WO2006060819A3 (en) Dhmeq as a sensitizing agent for chemotherapy and immunotherapy of resistant cancer cells
WO2011056566A3 (en) Compounds and methods for treatment of cancer
ZA200709542B (en) Combination therapy in the treatment of cancer
WO2010065563A3 (en) Apratoxin therapeutic agents: mechanism and methods of treatment
WO2008098183A3 (en) Combination therapy for treating cancer
MX2020013883A (en) Oncology treatments using zinc agents.
HK1074840A1 (en) Novel dithiolopyrrolones with therapeutic activity
BRPI0806257A2 (en) method of treatment and use of an immunotherapeutic composition
WO2009038771A3 (en) Tolperisone and tolperisone-like drugs for the treatment of k-ras associated cancers
TW200503798A (en) Arsenic-containing pharmaceutical composition for treatment of tumor/cancer in conjunction with radiation therapy

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees